Corcept Therapeutics Inc
CORT· Nasdaq
Released May 2, 2017, after the close
10-Q filed May 2, 2017, 32 days after period end · 0001564590-17-008133
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Revenue | $27.60M | $16.06M | $10.10M | $4.41M |
| Net Income | $4.39M | -$19.00K | -$4.83M | -$13.93M |
| EPS Diluted | $0.04 |
Corcept Therapeutics Inc · CIK 1088856 · Engraved from SEC EDGAR
| $0.00 |
| -$0.05 |
| -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.